Maude Poirier
About Maude Poirier
Maude Poirier is a Senior Clinical Trial Manager at Bristol Myers Squibb in Princeton, New Jersey, with over 15 years of experience in the pharmaceutical and clinical research industry.
Company
Maude Poirier is currently employed at Bristol Myers Squibb, a global biopharmaceutical company, located in Princeton, New Jersey. Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Maude Poirier holds the position of Senior Clinical Trial Manager at Bristol Myers Squibb. In this role, she oversees clinical trials, ensuring that they are conducted efficiently and comply with regulatory standards.
Education and Expertise
Maude Poirier pursued her higher education at the Université de Montréal, earning a Master of Science (M.Sc.) in Chemistry from 2007 to 2009. Prior to that, she completed her Bachelor of Science (B.Sc.) in Pharmaceutical Chemistry at Université de Sherbrooke from 2003 to 2006. Her educational background has provided her with a strong foundation in chemistry and pharmaceutical sciences.
Professional Background
Maude Poirier has accumulated over 15 years of experience in the pharmaceutical and clinical research industry. She began her career as a Coop Research Assistant at various companies, including MethylGene Inc., Amgen, Eisai Research Institute, and Centre de Recherches Cliniques de l’Université de Sherbrooke. She then worked as a Research Associate at Boehringer Ingelheim (Canada) Ltd. in Quebec, Canada, for three years. She joined Bristol Myers Squibb in 2013 as an Associate Research Scientist II in the Greater New York City Area, before transitioning to her current role as Senior Clinical Trial Manager in Princeton, New Jersey.
Transition to Clinical Trial Management
Throughout her career, Maude Poirier has demonstrated versatility by transitioning from research-focused roles to clinical trial management. Her experience spans both the United States and Canada, contributing to her international expertise in the field. Her progression at Bristol Myers Squibb highlights her capability to adapt and excel in different areas of the pharmaceutical industry.